The synergies gained from the HDACi and PD-1 would promote the antigen presentation of tumor-associated antigens (TAAs) on the tumor surface, induce the upregulation of major histocompatibility complex (MHC) molecules and initiate antigen-specific T cell immune responses (Chen X et al., 2020). This evidence concerns the gene HLA-C and neoplasm.